Lack of a relationship between the polymorphism of debrisoquine oxidation and lung cancer - Wikidata - wikimedia - TriplyDB

Lack of a relationship between the polymorphism of debrisoquine oxidation and lung cancer

Lack of a relationship between the polymorphism of debrisoquine oxidation and lung cancer

http://www.wikidata.org/entity/Q34358477

about

The debrisoquine metabolic phenotype and DNA-based assays: implications of misclassification for the association of lung cancer and the debrisoquine metabolic phenotype Cancer risk related to genetic polymorphisms in carcinogen metabolism and DNA repair.Interaction between dose and susceptibility to environmental cancer: a short review.The molecular epidemiology of lung cancer.The sparteine/debrisoquine (CYP2D6) oxidation polymorphism and the risk of lung cancer: a meta-analysis.

P2860

Q34843826-3A72DDB5-6B6B-44B2-A8E5-B7FAF8616E8E Q40897262-51F14781-A82C-47C0-879E-C111A0A5706A Q41561466-65A58623-4D2A-4F7E-9ED4-62B7DD897123 Q41570913-98828A18-0693-4904-8579-10AA203D5720 Q52892865-2F2F5E30-79AD-479D-BA08-1C805E0E65AE

P2860

Lack of a relationship between the polymorphism of debrisoquine oxidation and lung cancer

http://www.wikidata.org/entity/Q34358477

description

1991 nî lūn-bûn

@nan

1991 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

1991 թվականի մայիսին հրատարակված գիտական հոդված

@hy

1991年の論文

@ja

1991年論文

@yue

1991年論文

@zh-hant

1991年論文

@zh-hk

1991年論文

@zh-mo

1991年論文

@zh-tw

1991年论文

@wuu

name

Lack of a relationship between the polymorphism of debrisoquine oxidation and lung cancer

@ast

Lack of a relationship between the polymorphism of debrisoquine oxidation and lung cancer

@en

Lack of a relationship between the polymorphism of debrisoquine oxidation and lung cancer

@nl

type

label

Lack of a relationship between the polymorphism of debrisoquine oxidation and lung cancer

@ast

Lack of a relationship between the polymorphism of debrisoquine oxidation and lung cancer

@en

Lack of a relationship between the polymorphism of debrisoquine oxidation and lung cancer

@nl

prefLabel

Lack of a relationship between the polymorphism of debrisoquine oxidation and lung cancer

@ast

Lack of a relationship between the polymorphism of debrisoquine oxidation and lung cancer

@en

Lack of a relationship between the polymorphism of debrisoquine oxidation and lung cancer

@nl

P1433

Q34358477-1AEAF458-0E2D-4E7C-9FC1-CAAC232C303D

P1476

Q34358477-B38E0168-6C40-4585-9062-8C2FFD3D44F7

P2093

Q34358477-0AFA5A56-D181-49D4-9DDC-E25DF2666C59

Q34358477-15B7BF83-48F7-4616-87AD-5D35BEF999FE

Q34358477-20C36A48-1442-4F5B-A0D4-DE0068B57403

Q34358477-217BC66C-178F-4E0F-B9BB-959095BB6EE9

Q34358477-6AEAB1B2-F902-4DBB-A6F3-D5A6F920AD86

Q34358477-71B2EE77-2C11-4E24-89DE-2946FE0CC98E

Q34358477-C6DEE702-8F09-4E3B-8670-685A30192E39

Q34358477-C8ABB5A0-9919-4CC0-81DA-77089162A4FF

Q34358477-CE1D4A13-CD8A-4564-94F3-323FDB88C033

P2860

Q34358477-05122C7C-64CD-439D-A0D2-A96FCF9C8939

Q34358477-2DD134D2-2B95-49E2-811B-2869DFBB250A

Q34358477-32437454-EE68-4DA1-B95D-8144850E0680

Q34358477-55A34318-C014-411C-9851-51647834F49B

Q34358477-595DADF7-42F3-4C42-8F0B-F1A8F9ED898E

Q34358477-6C46DB89-AABB-4D2F-BCF2-29656A150E5C

Q34358477-94A871A5-7EAD-4040-B9D1-7B5DC6A1AEEA

Q34358477-C9A6D725-5DFA-400A-8F00-0AAF0B27D252

Q34358477-D74ABB6E-8BD0-43AF-8849-C157704EB976

Q34358477-DCE3AB70-7E5E-448B-BAC5-01350DC2208B

P304

Q34358477-600B38A2-0B81-4951-A1A3-5EB88EC9B2D5

P31

Q34358477-3B4A21DA-96E9-4B36-B25D-1F28F6F4BFA0

P356

Q34358477-1CE2FAC7-BC98-490E-8EEF-C84E3D0FB85A

P407

Q34358477-0CED9FC2-AFCD-41DB-8ADE-2E01F2F7F468

P433

Q34358477-72B54B15-46B7-4E50-A354-631BCFFF512C

P478

Q34358477-6652E5B8-6FA7-4ECC-9E0D-2E3CB327B567

P577

Q34358477-7CA02531-3B2D-49B2-A266-CB5EF6C09F7F

P5875

Q34358477-1C42CFEB-E68D-41D7-B4D8-02685CC78177

P698

Q34358477-3EC2BE38-EC81-4E1B-9BF9-0A9058AABA1E

P932

Q34358477-D8179249-A826-4D16-8449-F5350AFD7211

P356

J.1365-2125.1991.TB05575.X

P1433

British Journal of Clinical Pharmacology

P1476

Lack of a relationship between the polymorphism of debrisoquine oxidation and lung cancer

@en

P2093

Barre J

http://www.w3.org/2001/XMLSchema#string

Bechtel P

http://www.w3.org/2001/XMLSchema#string

Brochard P

http://www.w3.org/2001/XMLSchema#string

Dalphin JC

http://www.w3.org/2001/XMLSchema#string

Depierre A

http://www.w3.org/2001/XMLSchema#string

Duche JC

http://www.w3.org/2001/XMLSchema#string

Joanne C

http://www.w3.org/2001/XMLSchema#string

Tillement JP

http://www.w3.org/2001/XMLSchema#string

de Cremoux H

http://www.w3.org/2001/XMLSchema#string

P2860

A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.

Characterization of the common genetic defect in humans deficient in debrisoquine metabolism.

Polymorphic hydroxylation of Debrisoquine in man.

Debrisoquine oxidation phenotype and susceptibility to lung cancer.

Polymorphism of dextromethorphan oxidation in a French population

The influence of enzyme induction on polymorphic sparteine oxidation.

Quinidine: potent inhibition of sparteine and debrisoquine oxidation in vivo.

Quinidine and the identification of drugs whose elimination is impaired in subjects classified as poor metabolizers of debrisoquine.

P450 genes: structure, evolution, and regulation.

Clinical biostatistics. XXXIV. The other side of 'statistical significance': alpha, beta, delta, and the calculation of sample size.

P304

533-536

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2125.1991.TB05575.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

1991-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

21266607

http://www.w3.org/2001/XMLSchema#string

P698

1888620

http://www.w3.org/2001/XMLSchema#string

P932

1368471

http://www.w3.org/2001/XMLSchema#string